ArticleUrology case reports2026
Recurrent bilateral chyluria after lymphatic embolization successfully treated with renal pelvic instillation sclerotherapy: a case report.
Article in Urology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chyluria is a rare condition caused by abnormal communication between the lymphatic system and the urinary tract. We report a case of recurrent bilateral chyluria in a 65-year-old woman who previously underwent lymphatic embolization but developed persistent symptoms. Retrograde pyelography demonstrated bilateral renal lymphatic reflux. The patient was treated with bilateral renal pelvic instillation sclerotherapy (RPIS) using povidone iodine for three consecutive days. Symptoms resolved rapidly and no complications occurred. The patient remained symptom-free during 36 months of follow-up. This case highlights RPIS as a minimally invasive therapeutic alternative for recurrent chyluria after failed lymphatic embolization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.